The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Angioimmunoblastic T‐cell lymphoma
Open accessAbstract
The disease currently recognized as angioimmunoblastic T-cell lymphoma (AITL) was first described in the 1970s as a clinical syndrome characterized by generalized lymphadenopathy, hepatosplenomegaly, anaemia and hypergammaglobulinaemia (Frizzera et al, 1974; Lukes & Tindle, 1975; Lennert, 1979). The lymph node histology was observed to show a number of distinctive features such as the partial effacement of normal architecture by a polymorphic inflammatory infiltrate, including large blasts and marked vascular proliferation. Based on these histological appearances, the disease was initially referred to by a variety of terms, including immunoblastic lymphadenopathy (Lukes & Tindle, 1975), lymphogranulomatosis X (Lennert, 1979) and angioimmunoblastic lymphadenopathy with dysproteinaemia (AILD) (Frizzera et al, 1974). The latter term was accepted by most investigators and has come to define this clinical syndrome. AILD was initially thought to be an atypical lymphoid hyperplasia, a premalignant lesion, with a tendency to develop into a lymphoma rather than a frank neoplasm at onset. With the advent of immunophenotyping and molecular techniques, it became apparent that most cases of AILD contained monoclonal T-cell populations as well as clonal cytogenetic abnormalities, strongly suggesting that the majority of the patients were neoplastic from the onset. AITL was included in the Updated Kiel Classification for Lymphomas (Stansfeld et al, 1988) and is accepted as a distinct clinicopathological entity in the current WHO classification (Jaffe et al, 2001). It is likely that earlier series, published before the availability of immunophenotyping and molecular tests, are diluted by a number of reactive proliferations. In this review, as far as possible, we have used the data from relatively recent reports published after the neoplastic nature of AITL was established. No consistent risk factors for the development of the disease have been reported and to date no aetiological agent has been identified. A significant proportion of patients have a history of drug use (Tobinai et al, 1988; Sasaki & Sumida, 2000), in particular, antibiotics. These are more likely to represent drugs prescribed to the patients because of systemic illness clinically mimicking an infectious process, rather than the primary cause of the disease. A number of infectious diseases and agents have been reported to be associated with AITL, including bacterial infections such as tuberculosis (Rho et al, 1996) and fungal infections such as cryptococcus (Konig et al, 1991). Perhaps most intriguing is the relationship of AITL with a number lymphotropic viruses. The most significant of these is the Epstein–Barr virus (EBV), which is discussed separately below. The presence of other viruses, including human herpes virus (HHV)-6 (Luppi et al, 1993), HHV-8 (Luppi et al, 1996), human immunodeficiency virus (HIV) (Helm et al, 1990) and hepatitis C virus (Luppi & Torelli, 1996), have been reported in AITL. Other than EBV, the evidence for the role of a viral infection in the pathogenesis of AITL remains tenuous. HHV-6 was reported in seven out of 12 AITL patients identified by the polymerase chain reaction (PCR) (Luppi et al, 1993), but immunohistochemistry (Luppi et al, 1998) and in situ hybridization studies (Khan et al, 1993) showed that the expression of HHV-6 antigens was absent in the T cells, which is suggestive of a lack of a direct role for HHV-6. Occasional cases of AITL have also been described to have HHV-8 infection by PCR, but we (unpublished data) and others (Chadburn et al, 1997) failed to observe any evidence of HHV8 infection by PCR or immunohistochemistry in AITL, which, once again, argues against a causal relationship. Associations with other viruses are limited to a few case reports and are likely to be coincidences. The lymph node biopsy of AITL is characterized by the partial effacement of the lymph node architecture by a polymorphic infiltrate, predominantly occupying the paracortical (interfollicular) areas. Usually the lymph node sinuses are preserved but the infiltrate leaks into the perinodal tissue. In the original descriptions of AITL, the absence of reactive hyperplastic B-cell follicles was considered to be a characteristic feature; it is now recognized that the architectural changes in AITL fall into three overlapping patterns (Ree et al, 1998, 1999; Attygalle et al, 2002a). In pattern I (20% of the patients), there is a preservation of the lymph node architecture. Hyperplastic B-cell follicles with poorly developed mantle zones and ill-defined borders are easily identifiable in the cortex of the lymph node. These merge into the expanded paracortex containing a polymorphic infiltrate of lymphocytes, transformed large lymphoid blasts, occasional multinucleate cells that are reminiscent of Reed–Sternberg cells (RS), plasma cells, macrophages and eosinophils within a prominent vascular network (Fig 1). Histological appearances of A
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
Hossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,625
RHO GTPASES: Biochemistry and Biology
Jaffe, A. B., & Hall, A. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.020604.150721 · Cited by 3,009
Breitfeld, D., Ohl, L., Kremmer, E., Ellwart, J., Sallusto, F., Lipp, M., & Förster, R. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1545 · Cited by 1,464
UPDATED KIEL CLASSIFICATION FOR LYMPHOMAS
Stansfeld, A. G., Diebold, J., Kapanci, Y., Kelényi, G., Lennert, K., Mioduszewska, O., Noel, H., Rilke, F., Sundstrom, C., Van Unnik, J. A. M., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90367-4 · Cited by 1,149
Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation
Palacios, E. H., & Weiss, A. (2004) · Oncogene · doi:10.1038/sj.onc.1208074 · Cited by 714
ANGIO-IMMUNOBLASTIC LYMPHADENOPATHY WITH DYSPROTEINÆMIA
Frizzera, G., Moran, E. M., & Rappaport, H. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90553-4 · Cited by 517
Angio-immunoblastic lymphadenopathy with dysproteinemia
Frizzera, G. (1974) · The Lancet · Cited by 461
The neprilysin (NEP) family of zinc metalloendopeptidases: Genomics and function
Turner, A. J., Isaac, R. E., & Coates, D. (2001) · BioEssays · doi:10.1002/1521-1878(200103)23:3<261::aid-bies1036>3.0.co;2-k · Cited by 452
Rüdiger, T., Weisenburger, D. D., Anderson, J. R., Armitage, J. O., Diebold, J., MacLennan, K. A., Nathwani, B. N., Ullrich, F., & Müller-Hermelink, H. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf033 · Cited by 419
Cited by
Metabolic Regulation of Epigenetics
Lu, C., & Thompson, C. B. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.001 · Cited by 699
T Follicular Helper (TFH) Cells in Normal and Dysregulated Immune Responses
King, C., Tangye, S. G., & Mackay, C. R. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090344 · Cited by 632
de Leval, L., Rickman, D. S., Thielen, C., Reynies, A. D., Huang, Y.-L., Delsol, G., Lamant, L., Leroy, K., Brière, J., Molina, T., et al. (2007) · Blood · doi:10.1182/blood-2006-10-055145 · Cited by 631
Bryant, V. L., Ma, C. S., Avery, D. T., Li, Y., Good, K. L., Corcoran, L. M., de Waal Malefyt, R., & Tangye, S. G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8180 · Cited by 499
Mourad, N., Mounier, N., Brière, J., Raffoux, E., Delmer, A., Feller, A., Meijer, C. J. L. M., Emile, J.-F., Bouabdallah, R., Bosly, A., et al. (2008) · Blood · doi:10.1182/blood-2007-08-105759 · Cited by 346
Metadata
- Authors
- Dogan, A., Attygalle, A. D., & Kyriakou, C.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2003-05-28
- Volume
- 121
- Issue
- 5
- Pages
- 681-691
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2139422160
- Cited by
- 318
- References
- 44
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Angioimmunoblastic T‐cell lymphoma. https://app.cochat.ai/papers/10.1046/j.1365-2141.2003.04335.x
- The paper
- Dogan, A., Attygalle, A. D., & Kyriakou, C. (2003). Angioimmunoblastic T‐cell lymphoma. British Journal of Haematology. https://doi.org/10.1046/j.1365-2141.2003.04335.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.